These results, together with a earlier report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the principle of targeting ACKR3 as a unique solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-relevant Conditions. Healthy joints permit us to https://williamy170tsp1.tnpwiki.com/user